ALS standard of care consensus conference
- 1 April 1997
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 48 (4_suppl_4) , 1S
- https://doi.org/10.1212/wnl.48.4_suppl_4.1s
Abstract
An unprecedented amount of research activity has produced a greater understanding of the pathophysiology of ALS. There are now several potential pathogenic mechanisms that provide avenues for drug development. The positive results in clinical trials evaluating riluzole, a glutamate antagonist, supports the excitotoxicity …Keywords
This publication has 0 references indexed in Scilit: